S-23 Ultima Pharmaceuticals Research Overview
S-23 is a non-steroidal selective androgen receptor modulator (SARM) developed for investigational use in laboratory environments. This compound functions as a full agonist of androgen receptors with high binding affinity, distinguishing it from partial agonist compounds within the SARM class. Research scientists at Stroid UK Shop utilise S-23 to examine androgen receptor interaction mechanisms and tissue-selective androgenic activity patterns in controlled experimental models. The compound demonstrates unique properties that have made it valuable for studying spermatogenesis and hormonal contraceptive mechanisms in animal research protocols.
Research Applications and Mechanisms
S-23 exhibits distinct characteristics as a full androgen receptor agonist, offering researchers opportunities to investigate complete receptor activation pathways. Preclinical studies have explored its effects on bone density, muscle tissue development, and reproductive system function in rodent models. The compound’s mechanism involves selective binding to androgen receptors with particular relevance to studies examining male hormonal contraception. Laboratory investigations focus on evaluating S-23’s tissue-selective properties compared to traditional androgenic compounds. Researchers studying S-23 compounds examine its potential applications in understanding androgen receptor biology and hormonal regulation mechanisms. The compound’s reversible effects on spermatogenesis have generated interest within reproductive biology research fields.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | S-23 |
| CAS Number | 1010396-29-8 |
| Molecular Formula | C₁₈H₁₃ClF₄N₂O₃ |
| Molecular Weight | 416.75 g/mol |
| Classification | Non-steroidal SARM |
| Storage Conditions | Room temperature, dry environment |
| Manufacturer | Ultima Pharmaceuticals |
Research laboratories studying SARM compounds benefit from S-23’s well-characterised molecular properties and stability profile. The compound maintains structural integrity under standard laboratory storage conditions, ensuring consistent experimental results across research protocols. Scientists investigating broader compound classes may also examine peptide research materials for comparative mechanism studies.
Research Compliance and Safety
S-23 from Ultima Pharmaceuticals is manufactured exclusively for in-vitro laboratory research applications. This compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must adhere to appropriate safety protocols and institutional guidelines when handling this material. All studies should be conducted by qualified personnel in properly equipped laboratory facilities with adequate ventilation and safety measures.
